Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Название:Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость
- Автор:
- Жанр:
- Издательство:Питер
- Год:2020
- Город:Санкт-Петербург
- ISBN:978-5-4461-1021-6
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Ли Ноу - Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость краткое содержание
В нашем организме работают крошечные «энергетические станции» — митохондрии. Именно они отвечают за наше здоровье и отличное самочувствие. Когда они работают хорошо, мы не испытываем недостатка в энергии. А когда плохо — страдаем от заболеваний. Доктор Ли Ноу открывает тайну: заболевания, которые кажутся не связанными между собой на первый взгляд: диабет, рак, шизофрения, хроническая усталость, болезнь Паркинсона и другие — имеют общую природу.
Сегодня нам известно, как улучшить работу митохондрий, обеспечивающих организм энергией на 90 %. В этой книге вас ждет актуальная информация о питании, образе жизни, кетогенной диете и добавках, которые возвращают здоровье митохондриям, а следовательно, и нам.
Эгоистичная митохондрия. Как сохранить здоровье и отодвинуть старость - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
Kurban R. S., Bhawan J. Histologic changes in skin associated with aging. J Dermatol Surg Oncol. 1990 Oct; 16(10):908–14.
Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol. 2007 Feb; 292(2):C670–C686. Epub 2006 Oct 4. doi:10.1152 /ajpcell.00213.2006.
Passi S., et al. Lipophilic antioxidants in human sebum and aging. Free Radic Res. 2002 Apr; 36(4):471–7.
Passi S., et al. The combined use of oral and topical lipophilic antioxidants increases their levels both in sebum and stratum corneum. Biofactors. 2003; 18(1–4):289–97. doi:10.1002 /biof.5520180233.
Rusciani L., et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol. 2006 Feb; 54(2):234–41. doi:10.1016 /j.jaad.2005.08.031.
Treiber N., et al. The role of manganese superoxide dismutase in skin aging. Dermatoendocrinol. 2012 Jul 1; 4(3):232–5. doi:10.4161/derm.21819. Uitto J., Bernstein E. F. Molecular mechanisms of cutaneous aging: connective tissue alterations in the dermis. J Investig Dermatol Symp Proc. 1998 Aug;3(1):41–4.
Waller J. M., Maibach H. I. Age and skin structure and function, a quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and structure. Skin Res Technol. 2006 Aug; 12(3):145–54. doi:10.1111/j.0909-752X.2006.00146.x.
Al Rawi S., et al. Postfertilization autophagy of sperm organelles prevents paternal mitochondrial DNA transmission. Science. 2011 Nov 25; 334(6059):1144–7. Epub 2011 Oct 27. doi:10.1126/science.1211878.
Baylis F. The ethics of creating children with three genetic parents. Reprod Biomed Online. 2013 Jun; 26(6):531–4. Epub 2013 Mar 26. doi:10.1016/j. rbmo.2013.03.006.
Chappel S. The role of mitochondria from mature oocyte to viable blastocyst. Obstet Gynecol Int. 2013:1–10. Epub 2013 May 16. doi:10.1155/2013/183024.
Colagar A. H., et al. T4216C mutation in NADH dehydrogenase I gene is associated with recurrent pregnancy loss. Mitochondrial DNA. 2013 Oct; 24(5):610–2. Epub 2013 Mar 6. doi:10.3109/19401736.2013.772150. Cotterill M., et al. The activity and copy number of mitochondrial DNA in ovine oocytes throughout oogenesis in vivo and during oocyte maturation in vitro. Mol Hum Reprod. 2013 Jul; 19(7):444–50. Epub 2013 Mar 5. doi:10.1093/molehr/gat013.
Eichenlaub-Ritter U. Oocyte aging and its cellular basis. Int J Dev Biol. 2012; 56(10–12):841–52. doi:10.1387/ijdb.120141ue.
Grindler N. M., Moley K. H. Maternal obesity, infertility and mitochondrial dysfunction: potential mechanisms emerging from mouse model systems. Mol Hum Reprod. 2013 Aug; 19(8): 486–94. Epub 2013 Apr 23. doi:10.1093/molehr/gat026.
Kang E., et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature. 2016 Dec 8;540(7632):270–5. doi:10.1038/nature20592.
Latorre-Pellicer A., et al. Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing. Nature. 2016 Jul 28; 535(7613):561–5. Epub 2016 Jul 6. doi:10.1038/nature 18618.
Pang W., et al. Low expression of Mfn2 is associated with mitochondrial damage and apoptosis in the placental villi of early unexplained miscarriage. Placenta. 2013 Jul; 34(7):613–8. Epub 2013 Apr 17. doi:10.1016/j. placenta.2013.03.013.
Sato M., Sato K. Degradation of paternal mitochondria by fertilization-triggered autophagy in C. elegans embryos. Science. 2011 Nov 25; 334(6059):1141–4. doi:10.1126/science.1210333.
Tillett T. Potential mechanism for PM10 effects on birth outcomes: in utero exposure linked to mitochondrial DNA damage. Environ Health Perspect. 2012 Sep; 120(9):A363. doi:10.1289 /ehp.120-a363b.
Zuccotti M., Redi C. A., Garagna S. Study an egg today to make an embryo tomorrow. Int J Dev Biol. 2012; 56(10–12):761–4. doi:10.1387/ ijdb.130027mz.
Banerjee D., et al. Mitochondrial genome analysis of primary open angle glaucoma patients. PLoS One. 2013 Aug 5; 8(8):e70760. doi:10.1371/ journal.pone.0070760.
Blasiak J., et al. Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int J Mol Sci. 2013 Feb;14(2):2996–3010. Epub 2013 Jan 31. doi:10.3390 /ijms14022996.
Chen S. D., Wang L., Zhang X. L. Neuroprotection in glaucoma: present and future. Chin Med J (Engl). 2013 Apr; 126(8):1567–77. doi:10.3760/ cma.j.issn.0366–6999.20123565.
Ghiso J. A., et al. Alzheimer’s disease and glaucoma: mechanistic similarities and differences. J Glaucoma. 2013 Jun — Jul; 22 Suppl 5:S36–S38. doi:10.1097/IJG.0b013e3182934af6.
Izzotti A., et al. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol. 2010 Jun; 128(6):724–30. doi:10.1001/archophthalmol.2010.87.
Lee V., et al. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging. 2012 Oct; 33(10):2382–9. Epub 2012 Jan 2. doi:10.1016/j.neurobiolag-ing.2011.
Wang M. Y., Sadun A. A. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013 Jun;33(2):172–8. doi:10.1097/ WNO.0b013e3182901969.
Conboy I. M., Rando T. A. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle. 2005 Mar; 4(3):407–10. doi:10.4161/cc.4.3.1518. Flynn J. M., Melov S. SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic Biol Med. 2013 Sep; 62:4–12. Epub May 29 2013. doi:10.1016/j.freeradbiomed.2013.05.027.
Garcia M. L., Fernandez A., Solas M. T. Mitochondria, motor neurons and aging. J Neurol Sci. 2013 Jul 15. Epub 2013 Apr 26. doi:10.1016/j. jns.2013.03.019.
Hosoe K., et al. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007 Feb; 47(1):19–28. doi:10.1016/j. yrtph.2006.07.001.
Katajisto P., et al. Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science. 2015 Apr 17; 348(6232):340–3. Epub 2015 Apr 2. doi:10.1126/sci-ence.1260384.
Sahin E., DePinho R. A. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010 Mar 25;464(7288):520–8. doi:0.1038/nature08982.
Adams J. S., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998 Aug 28; 281(5318):1322–6.
Brown J. M. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther. 2002 Sep — Oct; 1(5):453–8. doi:10.4161/ cbt.1.5.157.
Bui T., Thompson C. B. Cancer’s sweet tooth. Cancer Cell. 2006 Jun; 9(6):419–20. doi:10.1016 /j.ccr.2006.05.012.
Carracedo A., Cantley L. C., Pandolfi P. P. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013 Apr; 13(4):227–32. Epub 2013 Feb 28. doi:10.1038/nrc3483.
Christofferson, T. Tripping over the truth: how the metabolic theory of cancer is overturning one of medicine’s most entrenched paradigms. White River Junction, VT: Chelsea Green Publishing; 2017.
Dalla Via L., et al. Mitochondrial permeability transition as target of anticancer drugs. Curr Pharm Des. 2014; 20(2):223–44. Epub 2013 May 16. Davila A. F., Zamorano P. Mitochondria and the evolutionary roots of cancer. Phys Biol. 2013 Apr; 10(2):026008. Epub 2013 Mar 22. doi:10.1088/1478-3975/10/2/026008.
DeBerardinis R. J., et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A. 2007 Dec 4; 104(49):19345–50. doi:10.1073/pnas.0709747104.
DeBerardinis R. J., et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008 Jan; 7(1):11–20. doi:10.1016/j.cmet.2007.10.002.
Fantin V. R., St-Pierre J., Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006 Jun; 9(6):425–34. doi:10.1016/j.ccr.2006.04.023. Gottfried E., et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006 Mar 1; 107(5):2013–21. doi:10.1182/blood-2005-05-1795.
Gottlieb E., Tomlinson I. P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer. 2005 Nov; 5(11):857–66. doi:10.1038/nrc1737.
He X., et al. Suppression of mitochondrial complex I influences cell metastatic properties. PLoS One. 2013 Apr 22; 8(4):e61677. doi:10.1371/ journal.pone.0061677.
Hoang B. X., et al. Restoration of cellular energetic balance with L-carnitine in the neurobioenergetic approach for cancer prevention and treatment. Med Hypotheses. 2007; 69(2): 262–72. doi:10.1016/j.mehy.2006.11.049. Hung W. Y., et al. Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochim Biophys Acta. 2010 Mar; 1800(3):264–70. doi:10.1016/j.bba-gen.2009.06.006.
Ishikawa K., et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008 May 2; 320(5876):661–4. doi:10.1126/science.1156906.
Kiebish M. A., et al. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res. 2008 Dec; 49(12):2545–66. doi:10.1194/jlr.M800319-JLR200.
Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008 Jun; 13(6):472–82. doi:10.1016/j.ccr.2008.05.005.
Kulawiec M., Owens K. M., Singh K. K. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther. 2009 Jul; 8(14):1378–85.
Ladiges W., et al. A mitochondrial view of aging, reactive oxygen species and metastatic cancer. Aging Cell. 2010 Aug; 9(4):462–5. doi:10.1111/ j.1474–9726.2010.00579.x.
Lee H. C., Chang C. M., Chi C. W. Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev. 2010 Nov; 9 Suppl 1:S47–S58. doi:10.1016/j.arr.2010.08.009.
Li X., et al . Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 2013 Feb 25; 6(1):19. Epub. doi:10.1186/1756-8722-6-19.
Lin C. C., et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep. 2012; 2:785. Epub 2012 Nov 8. doi:10.1038/srep00785.
Ma Y., et al . Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim Biophys Acta. 2010 Jan; 1797(1):29–37. doi:10.1016 /j.bbabio.2009.07.008.
Modica-Napolitano J. S., Kulawiec M., Singh K. K. Mitochondria and human cancer. Curr Mol Med. 2007 Feb; 7(1):121–31. doi:10.2174/156652 407779940495.
Nicolson G. L., Conklin K. A. Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy. Clin Exp Metastasis. 2008; 25(2):161–9. doi:10.1007/s10585-007-9129-z.
Читать дальшеИнтервал:
Закладка:
